Další formáty:
BibTeX
LaTeX
RIS
@proceedings{888194,
author = {Pour, Luděk and Sandecká, Viera and Kaisarová, Petra and Adam, Zdeněk and Krejčí, Marta and Zahradová, Lenka and Klincová, Mária and Szturz, P. and Ševčíková, Sabina and Hájek, Roman},
booktitle = {15th Congress of the European Hematology Association},
keywords = {Multiple myeloma; Relapse; Survival; Treatment},
language = {eng},
title = {Extramedullary relapsed multiple myeloma has extremely poor prognosis even in the era of the new drugs},
year = {2010}
}
TY - CONF
ID - 888194
AU - Pour, Luděk - Sandecká, Viera - Kaisarová, Petra - Adam, Zdeněk - Krejčí, Marta - Zahradová, Lenka - Klincová, Mária - Szturz, P. - Ševčíková, Sabina - Hájek, Roman
PY - 2010
TI - Extramedullary relapsed multiple myeloma has extremely poor prognosis even in the era of the new drugs
KW - Multiple myeloma
KW - Relapse
KW - Survival
KW - Treatment
N2 - Our data showed higher incidence of EM relapse in comparison with 90's .Interval of survival after EM relapse and is extremely short if EM occurs, although all new drugs including IMIDs and bortezomib are used for the treatment. Our findings indicate that EM still means very poor prognosis of MM patients even in the era of the new effective drugs, especially if ST-EM occurs. We have not yet fully understood why the incidence of EM is so high in the last 4 years. In our opinion, the treatment of EM became a crucial problem in MM, and effective treatment is unfortunately not available.
ER -
POUR, Luděk, Viera SANDECKÁ, Petra KAISAROVÁ, Zdeněk ADAM, Marta KREJČÍ, Lenka ZAHRADOVÁ, Mária KLINCOVÁ, P. SZTURZ, Sabina ŠEVČÍKOVÁ a Roman HÁJEK. Extramedullary relapsed multiple myeloma has extremely poor prognosis even in the era of the new drugs. Online. In \textit{15th Congress of the European Hematology Association}. 2010. ISSN~0390-6078. [citováno 2024-04-24]
|
